Skip to main content

Table 1 Demographic and clinical data collected

From: Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study

Age (years), sex and ethnicity of patient

 

Date of data collection

 

Underlying diagnosis

 

Cumulative dose of ifosfamide received (g/m2)

 

Other chemotherapeutic agents used

 

Time elapsed since completion of ifosfamide and other chemotherapeutics (months)

 

Current medications

 

Complications (poor growth/fractures)

 

Growth velocity in year prior to investigations (cm/year)